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1. Summary 
The core of all small RNA silencing phenomena resides in a ribonucleoprotein 
(RNP) complex that minimally consists of a short, single-stranded RNA molecule and an 
Argonaute protein. In the case of short interfering RNAs (siRNAs) and microRNAs 
(miRNAs), the functional effector complex is called RNA Induced Silencing Complex, or 
RISC for short. In this work, I have analyzed (a) how this complex is assembled and (b) 
how such assembly cascades that ultimately lead to a functional RNP can be regulated. 
I could show that Argonaute becomes loaded with an siRNA, when it is still 
double-stranded. Furthermore, Argonaute has to cleave the passenger strand, which is 
bound to the guide strand, to efficiently release it and convert RISC into its active, 
functional configuration. This irreversible cleavage step enforces siRNA asymmetry. 
Thus, it may play an important role for the future design of potent siRNAs to mimimize 
off-target effects. If the passenger strand cannot be cleaved, it becomes removed intact 
by a bypass pathway, albeit at a greatly reduced speed. This is of relevance for miRNA 
duplexes displaying internal bulges or for Argonaute proteins lacking endonucleolytic 
cleavage activity, where in both cases passenger strand cleavage cannot occur. 
I could also demonstrate that the miRNA production cascade is not a rigid 
program that is being executed by default whenever a miRNA gene is transcribed. In the 
case of miR-138, the processing of its precursor transcript is regulated by the action of an 
inhibitory protein. This factor recognizes the precursor RNA hairpin and blocks the final 
cleavage step in all tissues with the exception of specific neuronal cells and fetal liver 
cells. These findings have contributed to a better understanding of how miRNA 
expression can be regulated. Differential processing of a precursor miRNA may allow the 
uncoupling of miRNA function from the transcriptional status of its genomic locus. We 
envision that such regulation enables tight but also dynamic control of miRNA 
expression and could be a more general way of regulating miRNA function. 
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2. Zusammenfassung 
Das Herzstück aller RNA silencing Phänomene, hervorgerufen durch kleine 
RNA-Stränge, ist ein Ribonukleoproteinkomplex (RNP), der in der Minimalvariante aus 
einem kurzen, einzelsträngigen RNA-Molekül und einem Argonaute Protein besteht. Im 
Falle von short interfering RNAs (siRNAs) und microRNAs (miRNAs) wird dieser 
funktionelle Effektorkomplex RNA Induced Silencing Complex (RNA-induzierter Silencing 
Komplex), kurz RISC, genannt. In dieser Arbeit habe ich analysiert, (a) wie dieser 
Komplex zusammengefügt wird und (b) wie derartige Assemblierungskaskaden, die 
letztendlich zu einem funktionellen RNP führen, reguliert werden können. 
Ich konnte zeigen, dass Argonaute mit einer siRNA beladen wird, die noch 
doppelsträngig ist. Zudem muss Argonaute den passenger-Strang schneiden, der am guide-
Strang gebunden ist, um ihn effizient freizugeben und um RISC in die aktive und 
funktionelle Konfiguration umzuwandeln. Dieser irreversible Vorgang verstärkt die 
Asymmetrie einer siRNA, weshalb dies eine wichtige Rolle bei der zukünftigen 
Konzeption von wirksamen siRNAs spielen könnte, um unspezifische Nebeneffekte zu 
vermeiden. Kann der passenger-Strang nicht geschnitten werden, wird er durch einen 
Umgehungsmechanismus intakt freigegeben, allerdings mit einer in hohem Maße 
reduzierten Geschwindigkeit. Diese Resultate haben Relevanz für miRNA-Duplexe, die 
interne Wölbungen aufweisen, und für Argonaute Proteine, die keine endonukleolytische 
Schneideaktivität aufweisen, wo in beiden Fällen der passenger-Strang nicht geschnitten 
werden kann. 
Ich konnte auch zeigen, dass die miRNA-Prozessierungskaskade keine starres 
Standardprogramm ist, das ausgeführt wird, sobald ein miRNA-Gen transkribiert wird. 
Im Falle von miR-138 wird die Prozessierung des Vorläufertranskripts von einem 
Inhibitorprotein gesteuert. Dieser Faktor erkennt die Vorläufer-RNA-Haarnadelstruktur 
und blockiert die finale Prozessierung in allen Geweben mit der Ausnahme von 
spezifischen neuronalen Zellen und Zellen der fötalen Leber. Diese Resultate haben zu 
einem besseren Verständnis der miRNA-Genexpression geführt, wo differenzielles 
Prozessieren einer Vorläufer-miRNA die Funktion der miRNA von ihrem 
transkriptionellen Status am genomischen Lokus entkoppeln könnte. Wir glauben, dass 
eine derartige Regulation eine straffe, aber gleichzeitig dynamische Kontolle der miRNA-
Genexpression erlaubt und dass dies eine etwas mehr verbreitetere Möglichkeit darstellen 
könnte, wie die Funktion von miRNAs reguliert wird. 
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3. Introduction to RNA silencing 
 
3.1. History 
In the year 1998, the concepts of regulation and control of gene expression 
were shaken by the seminal discovery of Andrew Fire, Craig Mello and colleagues, who 
conclusively demonstrated that injecting double-stranded ribonucleic acid (dsRNA) into 
C. elegans worms causes silencing of the cognate genes (Fire et al., 1998). All of a sudden, 
scientists were confronted with the alluring possibility to silence their favorite genes in 
vivo simply by introducing complementary dsRNA. 
However, first hints of such silencing already surfaced in the late 1980s and 
early 1990s, where plant biologists observed that introducing extra copies of a gene 
responsible for the purple color of petunia flowers had the exact opposite effect as 
expected: instead of a much deeper color, the flower leaves became white or patchy, and 
it seemed as if both the transgenes and the endogenous gene were silenced (Napoli et al., 
1990; van der Krol et al., 1990). A similar phenomenon was observed for plants infected 
with an RNA virus harboring fragments of an endogenous plant gene: its expression was 
silenced (Wassenegger et al., 1994). 
The observations were there, but only after the publication of Fire, Mello and 
colleagues the pieces of this puzzle fell into place. RNA interference (RNAi), as this 
phenomenon was named, is hypothesized to have evolved in ancient times as a defense 
system against rogue genetic elements, such as transposons or retro-viruses, who 
replicate and proliferate in the cell via dsRNA-intermediates (Hannon, 2002; Hannon 
and Rossi, 2004; Novina and Sharp, 2004). Obviously, eukaryotic cells consider dsRNA 
as a potential threat to their genomes and employ the RNAi machinery in an effort to 
eliminate such mobile, parasitic nucleic acids. The scientist can easily exploit this system 
to specifically silence any gene of interest, simply by introducing exogenous dsRNA 
molecules bearing sequence complementarity to a particular protein-coding messenger 
RNA (mRNA), which in turn is treated like a parasitic element: it is recognized, cleaved 
and degraded. RNAi can thus be used as a straightforward, reverse genetic approach in 
order to link gene sequence to biological function. 
Today, it is widely accepted that the discovery of RNAi has been the most 
important achievement in molecular biology since the invention of the polymerase chain 
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reaction (PCR). In 2006—only eight years after their groundbreaking publication—
Andrew Fire and Craig Mello were awarded the Nobel Prize in Physiology or Medicine, 
underscoring the relevance of their work. RNAi is now known to operate in plants and 
metazoan species and is extensively used as a genetic inactivation tool (Elbashir et al., 
2001a). Both biochemical and genetic analyses have contributed to our current 
mechanistic understanding of RNAi. Many key concepts, however, are still not fully 
understood. 
 
3.2. The mechanism of RNAi 
The trigger of RNAi is long dsRNA; it is recognized in the cell as foreign and a 
potential threat. Long dsRNA can emerge from various sources such as simultaneous 
sense and antisense transcription of specific genomic loci or viral replication 
intermediates (Peters and Meister, 2007). The actions the cell takes during the RNAi 
response can be divided into two distinct phases (Figure 1). In the initiation phase, the 
long dsRNA duplex is recognized and processed into short dsRNA molecules termed 
short interfering RNAs (siRNAs) (Bernstein et al., 2001; Hamilton and Baulcombe, 
1999). In entering the effector phase, siRNAs are unwound and one strand assembles 
into the RNA-induced silencing complex (RISC), a ribonucleoprotein (RNP) complex, 
where the small RNA operates as a template for the recognition and cleavage of cognate 
RNA molecules (Hammond et al., 2001; Martinez et al., 2002a). Here, the single stranded 
siRNAs are tightly associated with members of the Argonaute (Ago) family of proteins. 
They are named after the argonaute (AGO) phenotype in A. thaliana, which itself was 
named after its resemblance to argonauts, a group of pelagic octopuses (Bohmert et al., 
1998). 
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Figure 1. The mechanism of RNAi. 
Long dsRNA is recognized by the RNase III like enzyme Dicer and chopped into ~21 nt small interfering 
RNA (siRNAs). With the help of a dsRNA binding domain (dsRBD) protein these are loaded into 
Argonaute (Ago) proteins and serve as a guiding cue to target the RNA induced silencing complex (RISC) 
to complementary RNAs for their endonucleolytic cleavage and subsequent degradation. 
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3.2.1. The initiation phase 
The elegance of RNAi consists in converting the actual trigger of the 
response—long dsRNA—into small and versatile signaling units called siRNAs. These 
are, in turn, employed by the cellular machinery to act against the source of the long 
dsRNA by taking advantage of base complementarity and base pairing.  
3.2.1.1. Dicing the long dsRNA 
A crucial player in this step is the RNase III like enzyme Dicer that recognizes 
the dsRNA and processes it into ~21 nucleotide (nt) siRNA duplexes (Bernstein et al., 
2001; Elbashir et al., 2001a; Elbashir et al., 2001b; Filipowicz, 2005; Ketting et al., 2001; 
Knight and Bass, 2001; Provost et al., 2002). Dicer has a molecular weight of 
approximately 200 kDa and features a DExH RNA helicase/ATPase domain, DUF283 
and PAZ domains, two neighboring RNase III-like domains (RIIIa and RIIIb) and a C-
terminal dsRNA binding domain (dsRBD). The two RIIIa and RIIIb domains of the 
same Dicer molecule interact with each other, so that Dicer acts as a 
pseudodimer/intramolecular dimer. Dicer contains a single processing center, where 
dsRNA substrates are cleaved at approximately 20 bp from the 3! terminus bound by the 
PAZ domain (Kolb et al., 2005; Zhang et al., 2004). As a consequence of Dicer-mediated 
cleavage, siRNAs bear characteristic and functionally important 5!-phosphate groups and 
2-nt 3!-overhangs featuring 3!-hydroxyl groups.  
3.2.1.2. RISC assembly and siRNA asymmetry 
In metazoan species, Dicer functions in complex with a dsRBD protein. In D. 
melanogaster, Dicer-1 is associated with Loquacious (Forstemann et al., 2005; Jiang et al., 
2005) and Dicer-2 with R2D2 (Tomari et al., 2004). Mammalian Dicer cooperates with 
TRBP (the human immunodeficiency virus transactivating response RNA-binding 
protein) (Chendrimada et al., 2005; Haase et al., 2005), the ortholog of Loquacious. 
These dsRBD proteins are hypothesized to assist Dicer in the crucial step of RISC 
loading, where the siRNA is partially unwound and passed to Argonaute proteins. This 
process is very well studied in D. melanogaster, where the assembly process can be 
monitored by native gel electrophoresis (Pham et al., 2004). Apparently, the siRNA is not 
simply handed over by Dicer, but has to go through a series of intermediate complexes, 
termed pre-RISC and holo-RISC to finally become the mature RISC (Kim et al., 2007). 
In mammals, the picture is less clear. Results indicate that Dicer, TRBP and Ago2 are 
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sufficient to assemble on and unwind an siRNA duplex (Gregory et al., 2005; Maniataki 
and Mourelatos, 2005). 
An important concept during RISC loading and siRNA unwinding is siRNA 
asymmetry (Khvorova et al., 2003). siRNAs can be considered asymmetric according to 
the binding energy of the two 5!-ends. The greater the GC-content the more energy is 
required to unwind the respective 5!-end. In D. melanogaster, the dsRBD protein R2D2 
associated with Dicer-2 is able to sense this asymmetry. As a consequence, the strand, 
whose 5!-end is less stable according to the binding energy, is loaded into RISC (Tomari 
et al., 2004). It is less evident, how siRNA asymmetry is determined in mammals, 
however the binding energy of the 5!-ends plays a crucial role as well. 
3.2.1.3. Passenger strand removal 
Since an siRNA is typically asymmetric, the RNAi machinery is able distinguish 
the two siRNA strands. The strand, that will function in RISC, is called the “guide 
strand,” as it will serve as a guide to direct RISC to its target RNAs. The second strand is 
called “passenger strand,” as it just accompanies the guide strand in the siRNA duplex 
and is degraded after RISC assembly. A crucial question is, how is the passenger strand 
removed from the duplex? Does this process require an RNA helicase? Is the passenger 
strand removed intact or is it the “first target” of the assembling RISC? This process was 
scrutinized in four publications within three months using mammalian cells and D. 
melanogaster (Leuschner et al., 2006; Matranga et al., 2005; Miyoshi et al., 2005; Rand et al., 
2005). It is now well established that RISC cleaves the passenger strand during assembly 
and that this event is crucial for its fast and efficient removal. However, if a passenger 
strand cannot be cleaved by assembling RISC, it is removed intact by a so-called bypass 
pathway, which operates substantially slower. Only recently, first evidence of an RNA 
helicase acting during RISC assembly surfaced. Robb and Rana demonstrated that RNA 
helicase A interacts with the siRNA, Dicer, TRBP and Ago2 and show evidence for its 
activity during siRNA loading (Robb and Rana, 2007). However, this involvment requires 
further study and more experiments to obtain a clearer picture. 
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3.2.2. The effector phase 
3.2.2.1. Target RNA clevage 
Once an siRNA has been assembled into RISC, it serves as a molecular guide to 
target complementary RNAs. A single stranded RNA (ssRNA) associated with a protein 
of the Argonaute protein family is considered the hallmark of RNA silencing. This 
silencing is achieved by the action of the protein component of RISC, Ago (see 3.2.2.2), 
an endonuclease that—upon binding with a high degree of complementarity—cleaves or 
“slices” the target (Martinez et al., 2002a; Martinez and Tuschl, 2004; Schwarz et al., 
2004; Tomari and Zamore, 2005). 
RISC displays a weak affinity for ssRNA and is thereby able to promote the 
annealing of the siRNA to the target RNA. Since RISC is unable to open structured 
RNA, efficient binding is dependent on the secondary structure and the resulting 
accessibility of the target sequence. Here, the 5! part of the siRNA plays a very important 
role in establishing first contact to the target (Ameres et al., 2007). 
However, the siRNA in RISC does not only guide Ago to the target RNA but, 
once fully bound, it also acts as a “molecular ruler”. Counting from the 5!-end of the 
siRNA, Ago cleaves the phosphodiester bond across nucleotides 10 and 11 (Elbashir et 
al., 2001b; Elbashir et al., 2001c; Haley and Zamore, 2004; Martinez et al., 2002b). The 
cleavage products feature 5!-phosphate and 3!-hydroxyl termini, and Mg2+ is required for 
catalysis (Martinez and Tuschl, 2004; Schwarz et al., 2004). Furthermore, for cleavage to 
occur, only bases 2 to 12 need to be paired to the substrate RNA, corresponding to one 
full turn of an RNA:RNA helix (Chiu and Rana, 2003; Doench and Sharp, 2004; Haley 
and Zamore, 2004). 
After cleavage, the target RNA is released enabling RISC to start multiple series 
of catalysis (Haley and Zamore, 2004; Hutvágner and Zamore, 2002; Martinez and 
Tuschl, 2004). While RISC does not require ATP-hydrolysis for target RNA cleavage in 
single-turnover conditions, the presence of ATP has been shown to increase the rate of 
cleavage in multiple turnover conditions (Haley and Zamore, 2004). 
3.2.2.2. The family of Argonaute proteins 
The central mediators of RNA silencing are Argonaute proteins. These proteins 
come in different flavors, but all display a common domain structure (Figure 2). 
Argonautes belong to PAZ-PIWI-domain (PPD) proteins. They typically feature an N-
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terminal PAZ (PIWI-Argonaute-Zwille) and a C-terminal PIWI (P-element Induced 
Wimpy Testes) domain (Carmell et al., 2002; Cerutti et al., 2000). The PAZ domain can 
also be found in Dicer and is known to function as an RNA binding domain (Bernstein 
et al., 2001). The PIWI domain is involved in protein–protein interactions (Tahbaz et al., 
2004). Most importantly, the PIWI domain was also shown to adopt an RNase H like 
fold (Parker et al., 2004; Song et al., 2004). This result plus the findings that target RNA 
cleavage requires Mg2+ and leaves 5!-phosphates as well as 3!-hydoxy groups 
(Wintersberger, 1990) led to the conclusion that the PIWI domain harbors the elusive 
slicer activity. In mammals, however, Ago2 is the only paralog to display slicer activity in 
its PIWI domain (Liu et al., 2004; Meister et al., 2004; Song et al., 2004). 
Phylogenetically, the Argonaute family of proteins can be divided into three 
subfamilies: (a) the Argonaute subfamily, (b) the Piwi subfamily and (c) a subfamily only 
present in C. elegans (Yigit et al., 2006). In D. melanogaster, Ago1 and Ago2 represent the 
Argonaute subfamily, whereas Ago3, Aubergine and Piwi belong to the Piwi-subfamily. 
In vertebrates, “Ago”-proteins embody the Argonaute subfamily (Ago-1–4 in human, 
Ago 1–5 in mouse) with proteins from the Piwi-subfamily being denoted HIWI/HILI 
(HIWI-like) for human, MIWI/MILI for mouse, ZIWI for Zebrafish. 
 
 
 
Figure 2. Illustration of RISC bound to a target RNA as proposed by (Song et al., 2004) 
The PAZ domain (red) anchors the 3! end of the siRNA (yellow) inside its cleft and the 5! end on the distal 
end of the domain. The target mRNA (brown) bound by the siRNA reaches through the protein domains. 
The active site in the PIWI domain (shown as scissors) is positioned across the middle of the siRNA guide 
strand to cleave the target mRNA. 
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3.2.3. RNAi as a reverse genetic tool 
In an era, where the genomes of all important model organisms are sequenced 
and publicly available, it became evident that RNAi would allow easy and practicable 
loss-of-function studies for virtually all known genes. Instead of the tedious work to 
generate mutants, dsRNA bearing the sequence of the gene of interest has to be 
introduced. In C. elegans, feeding the worms with E. coli producing the desired dsRNA is 
enough to silence the gene of interest (Fire et al., 1998). In D. melanogaster, inverted 
repeats can be introduced into the fly genome, that feature a promoter, which can be put 
under tight transcriptional control (Dietzl et al., 2007). In higher eukaryotes such as 
mammals, long dsRNA cannot be used for efficient RNAi, since these organisms have 
developed an unspecific interferon-based, antiviral response to this trigger (Manche et al., 
1992; Stark et al., 1998). Here, dsRNA is recognized by the dsRNA-dependent protein 
kinase (PKR), a serine-threonine kinase that undergoes autophoshphorylation and then 
causes phosphorylation of downstream substrates. As a consequence, translation is shut 
down very rapidly leading to a pleiotropic effect of the dsRNA. To circumvent this 
problem, Dicer-like pre-processed siRNAs are used, since they are small enough to evade 
the interferon response (Elbashir et al., 2001a).  
3.3. microRNAs 
3.3.1. Discovery of microRNAs 
As mentioned above, RNAi is hypothesized to have evolved as a defense 
system against rogue genetic elements that replicate via long dsRNA intermediates. A 
major discovery, however, was the finding that higher eukaryotic cells harness the 
mechanisms of RNAi to regulate the expression of endogenous genes. Just as in the 
canonical RNAi pathway (Figure 1), short ssRNA molecules that are stably encoded in 
the genome serve as sequence specific guides to target RISC to cognate sequences 
typically present in the 3!-untranslated region (UTR) of messenger RNAs (mRNAs). 
These RNAs are called microRNAs (miRNAs) (Ambros, 2004). First reports of small 
RNAs regulating the expression of protein coding genes with complementary regions in 
the 3!-UTR of mRNAs were published before the “RNAi revolution” in 1998 (Lee et al., 
1993). At that time, miRNAs were called small temporal RNAs (stRNAs), since they 
were discovered as regulators in the developmental timing of C. elegans larval 
development (Grosshans et al., 2005; Lee et al., 1993; Reinhart et al., 2000). The 
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discovery of siRNAs encouraged scientists to look for endogenous small RNAs and to 
eventually decribe the class of miRNAs (Lagos-Quintana et al., 2001; Lagos-Quintana et 
al., 2003; Lagos-Quintana et al., 2002; Lau et al., 2001; Lim et al., 2003a; Lim et al., 
2003b; Reinhart et al., 2002). 
3.3.2. Biology of microRNAs 
Today, miRNAs are defined as a growing family of ~22 nt small, endogenous, 
non-coding RNAs (ncRNAs) that specifically regulate expression of complementary 
mRNAs (Kloosterman and Plasterk, 2006). While siRNAs can be derived from any part 
of long dsRNA molecules, miRNAs have a defined, unique sequence and are liberated in 
a non-random fashion from precursor dsRNA transcripts that fold into a typical stem-
loop structure. miRNAs act post-transcriptionally by binding complementary sequences 
in the 3!-UTR of particular mRNAs, causing translational repression or target mRNA 
cleavage. 
3.3.2.1. microRNA genomics 
miRNAs have been described in many organisms of both animal and plant 
kingdoms (Ambros, 2004; Kim and Nam, 2006), but they also exist in viruses 
(Baulcombe, 2004; Cullen, 2006; Pfeffer et al., 2004). Current estimates expect a few 
thousand miRNAs (Berezikov et al., 2005; Carthew, 2006; Lim et al., 2003a) that regulate 
approximately 20–30% of all genes (Brennecke and Cohen, 2003; Lewis et al., 2005). 
Such predictions are generated by sophisticated computer algorithms that scan genomes 
for sequences, which—upon transcription—fold into hairpin-like structures that are 
substrates for RNase III mediated cleavage. Employing secondary structure comparison, 
features could be defined that distinguish genuine RNase III substrate hairpins from 
other non-precursor hairpins (Ritchie et al., 2007). Another important criterion for 
miRNA prediction programs is evolutionary conservation at the sites of the potential 
hairpins. However, recent findings in eutherians indicate that in addition to strongly 
conserved miRNA families, such as the let-7 family, rapidly evolving miRNA genes exist 
that are only present in distinct classes of the animal kingdom (Houbaviy et al., 2005). 
miRNA genes are encoded in the genome in various fashions (Bartel, 2004; 
Kim, 2005). First, miRNAs can exist as individual, monocistronic transcription units 
where the miRNA is excised from a ncRNA transcript. Such loci are also termed 
“intergenic miRNAs”, since the neighboring genes are >1 kb away. Second, miRNAs can 
be embedded in introns as well as exons of protein coding or non-coding transcripts. 
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Here, miRNAs can reside in both the sense or the anti-sense orientation (Lagos-
Quintana et al., 2001; Lau et al., 2001). Third, miRNAs can also exist in so-called 
miRNA-clusters, where multiple miRNAs are serially encoded in a polycistronic 
transcript (Lee et al., 2002). Such a cluster, in turn, can reside in an autonomous 
transcription unit, or in an exon or intron of a host gene. It appears that the vast majority 
of miRNAs is transcribed by RNA polymerase II (Cai et al., 2004; Lee et al., 2004a). The 
human miR-19-cluster, which resides between Alu-repeats, is transcribed by RNA 
polymerase III, but this seems to be an exception rather than a common rule (Borchert 
et al., 2006). The use of RNA polymerase II promoters provides miRNAs with access to 
all the associated regulatory factors that allow tight transcriptional control both in space 
and time. Indeed, many miRNAs show specific expression patterns during 
developmental stages as well as under specific conditions and in certain cell types (Lagos-
Quintana et al., 2003; Lagos-Quintana et al., 2002). 
3.3.2.2. microRNA biogenesis 
The biogenesis of miRNAs (Figure 3) is similar in all organisms ranging from 
plants to animals (Murchison and Hannon, 2004) and shares many features with the 
canonical RNAi pathway (Figure 1). miRNAs are expressed as long, primary transcripts 
in the nucleus (pri-miRNAs), which are processed by the Microprocessor complex—
consisting of the dsRBD Pasha/DGCR8 and the RNase III like enzyme Drosha—into 
miRNA precursors (pre-miRNAs) (Kim, 2005). pre-miRNA hairpins show a 2-nt 3!-
overhang characteristic of RNase III cleavage, which is recognized by Exportin-5, a Ran–
GTP-dependent nuclear export factor (Bohnsack et al., 2004; Lund et al., 2004). Once 
translocated to the cytoplasm, pre-miRNA precursors are recognized by the Dicer–
Loquacious/TRBP complex, which liberates a ~22 nt duplex RNA. According to the 
asymmetry rules (see above) the duplex is unwound, the passenger or miRNA* strand 
removed and the mature miRNA loaded into RISC. The differences between mammalian 
RISC loaded with an siRNA or a miRNA are not yet fully understood (Meister et al., 
2004). However, both siRNAs, and miRNAs have been shown to guide target RNA 
cleavage for substrates with perfect complementarity, arguing that not the history of the 
short RNA molecules, but the degree of complementarity balances target cleavage versus 
translational repression (Doench et al., 2003). Consequently, siRNAs can act in a 
miRNA-manner when binding imperfectly to an RNA. 
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Figure 3. The miRNA pathway. 
miRNA primary transcripts that are generated by RNA polymerase II feature a 7-methyl-guanosine cap 
and a poly-A tail. They fold into a hairpin shaped structure that is recognized by the Microprocessor 
complex, consisting of the nuclear RNase III like enzyme Drosha and the dsRBD DGCR8/Pasha. The 
pri-miRNAs are cropped to pre-miRNAs, which in turn are recognized by Exportin-5 and transferred to 
the cytoplasm. The cytoplasmic RNase III like enzyme Dicer in complex with the dsRBD 
TRBP/Loquacious cleaves off the terminal loop, thereby generating the ~22 nt miRNA duplex. This 
duplex is loaded into Ago proteins, unwound and—as in the RNAi-pathway—serves as a molecular guide 
to target the miRNA-associated RISC (miRISC) to complementary RNAs. In case of target RNAs 
displaying perfect complementarity, miRNAs loaded into Ago2 proteins are able to cleave the target. 
However, the main function of miRNAs appears to be translational repression by imperfect binding to 
target RNAs. 
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In D. melanogaster, the siRNA and miRNA pathways are separated. The Dicer-1–
Loquacious complex cleaves pre-miRNAs and loads the miRNA into Ago1, whereas the 
Dicer-2–R2D2 complex cleaves long dsRNA into siRNAs that are shuttled to Ago2 (Lee 
et al., 2002; Pham et al., 2004). Two recent publications introduced the idea that the 
different intrinsic structures of siRNA/siRNA* and miRNA/miRNA* duplexes 
determine, where the small RNA will be loaded into (Forstemann et al., 2007; Tomari et 
al., 2007). Since the dsRNA–siRNA pathway does not seem to exist in mammals, only 
one Dicer paralog is present that functions in miRNA biogenesis and that is more closely 
related to Drosophila’s Dicer-1. 
Very recently, a novel class of miRNA-type regulatory RNAs were discovered 
(Okamura et al., 2007). These “miRNAs” are derived from short intronic hairpins termed 
mirtrons. Here, the requirement of Drosha-mediated cleavage is bypassed since mirtrons 
are generated by the splicing machinery and lariat-debranching enzyme. The resulting 
pre-miRNA-like hairpins are then channeled into the miRNA pathway downstream of 
Drosha and fed into the pool of functional miRNAs. 
3.3.2.3. Regulation of microRNA expression 
As mentioned above, the great majority of miRNAs is under the control of 
RNA polymerase II promoters (Cai et al., 2004; Lee et al., 2004a) explaining how 
miRNAs can display such distinct expression patterns. However, a detailed description of 
core miRNA promoters is still missing. Recently, a computational approach was able to 
uncover few basic motifs that are very similar to the already known cis-acting elements 
for the initiation of transcription (Zhou et al., 2007). In the past year, more and more 
evidence accumulated that the expression of miRNAs is not only regulated at the 
promoter but also post-transcriptionally in various modes. We demonstrated that the 
brain-specific miRNA miR-138 is ubiquitously transcribed but processing is inhibited in 
all tissues other than neurons of the neo-cortex, the hippocampus and the cerebellum, as 
well as cells of the fetal liver (Obernosterer et al., 2006) (see section 4.2). Shortly 
thereafter, Thompson and colleagues found that the expression of miRNAs can be 
extensively regulated by altering the levels of the RNase III like enzyme Drosha that 
initiates the miRNA–processing cascade (Thomson et al., 2006). These publications were 
followed by additional results confirming differential ratios between precursor and 
mature miRNAs indicative of post-transcriptional regulation (van Rooij et al., 2006). Just 
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recently, adenosine to inosine RNA editing was also found to affect the processing of 
pre-miR-151 by Dicer–TRBP (Kawahara et al., 2007).  
3.3.2.4. Silencing by microRNAs 
While plant miRNAs bind their cognate sequences with perfect 
complementarity leading to target cleavage, animal miRNAs almost exclusively show 
imperfect binding followed by a plethora of silencing phenomena (Pillai et al., 2007; 
Valencia-Sanchez et al., 2006). Despite these considerable differences in the regulatory 
output, the mechanism, how a miRNA finds and binds its target, appears to be 
conserved in all species. Genuine miRNA target sites contain a stretch of nucleotides 
that display perfect Watson–Crick complementarity to the 5! part of the miRNA, namely 
the bases 2–8 (Lewis et al., 2003). This heptamer is also called the miRNA “seed” and is 
absolutely essential for the binding of the miRNA. Indeed, perfect binding of the 
miRNA seed to a target site with all the other miRNA bases being unpaired is enough to 
yield functional silencing (Brennecke et al., 2005). However, minor flaws within the 
seed—such as a G:U wobble pair that would abrogate silencing—can be compensated by 
a strong binding of the 3! end of the miRNA. The requirement of seed-binding was 
already indicated earlier, at a time when miRNAs were not yet known (Lai et al., 1998). 
Here, a conserved sequence motif termed K-box was discovered in the 3! UTRs of 
Enhancer of split Complex genes that is essential for regulation of these genes by Notch 
receptor activity. 
The effect of seed-only regulation has to be taken into consideration whenever 
siRNAs are designed to target a specific mRNA. While the siRNA will silence the gene 
of interest via the RNAi pathway and target RNA cleavage, the same RISC can also act 
like a RISC loaded with a miRNA by binding to other mRNAs harboring accessible 
sequence motifs complementary to bases 2–8 of the siRNA. These messages are silenced 
via the miRNA-pathway and will of course contribute to the phenotype that is observed 
(Jackson et al., 2006). Such an unwanted result is called an “off target effect” and it is 
usually overcome by blasting the “siRNA seed” against the genome to check for any 
possible matches (Reynolds et al., 2004). 
But which mechanisms do miRNAs use to regulate their targets? The most 
prominent silencing mode of miRNAs appears to be translational repression (Bartel, 
2004; Olsen and Ambros, 1999). Whether RISC bound to the target site interferes with 
the initiation or elongation of translation is still a matter of debate, owing to the fact that 
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these experiments were performed using different systems (Jackson and Standart, 2007; 
Pillai et al., 2007). Repression can be observed directly at the initiation phase 
(Humphreys et al., 2005; Pillai et al., 2005), as well as at post-initiation phases (Maroney 
et al., 2006; Nottrott et al., 2006; Petersen et al., 2006). Very recently, a study implied the 
anti-association factor eIF6, that prevents assembly of the 80S ribosome, to associate 
with miRNA-associated RISC (miRISC) (Chendrimada et al., 2007). Furthermore, human 
Ago2 was found to contain a motif similar to the m(7)G cap-binding domain of eIF4E, 
an important translation initiation factor (Kiriakidou et al., 2007). This motif is essential 
for silencing by translational repression, potentially by binding the cap and thus 
preventing the recruitment of eIF4E. 
To allow efficient long-term silencing, miRISC has to be recycled. This occurs 
in the so-called processing bodies (p-bodies), where bound target RNAs are transported, 
decapped and subsequently degraded rapidly by exonucleases (Jakymiw et al., 2005; Liu 
et al., 2005; Sen and Blau, 2005). However, p-bodies have also been shown to act as 
storage facilities, from where repressed target RNAs can be recruited back to the 
cytoplasm for translation (Bhattacharyya et al., 2006). 
A different mode of silencing can be observed in the zebrafish D. rerio, where 
miRNAs were shown to affect the stability of the poly-A tail of mRNAs. The miRNA 
family miR-430 is required for the deadenylation of maternal mRNAs in the developing 
fish embryo (Giraldez et al., 2005), clearing the translation machinery for embryonic 
mRNAs. 
Finally, miRNAs displaying perfect complementarity to target sites can also lead 
to target RNA cleavage (Yekta et al., 2004), highlighting the functional equivalence of 
miRNA-associated RISC (miRISC) and siRNA-associated RISC (siRISC) in mammals. 
3.3.2.5. microRNA function 
In mammals, more than 200 miRNAs have been defined and annotated (Bartel, 
2004), but only very few target genes are known, because animal miRNAs bind cognate 
sequences imperfectly, thereby creating complex secondary structures. As a consequence, 
refined computational tools and elaborate algorithms need to be employed, in order to 
assign target genes to known miRNA sequences (Enright et al., 2003; Krek et al., 2005; 
Lewis et al., 2003; Rehmsmeier et al., 2004). So far the overlap between the various 
prediction programs has been very small, probably owing to differential ranking of 
parameters such as phylogenetic conservation of the target site, especially the seed, 
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folding energy and of course statistics. As a consequence, in silico predicted miRNA 
targets have to be validated in vivo. 
miRNAs regulate important biological and pathological processes, including cell 
differentiation, apoptosis, and cellular transformation [reviewed in (Ambros, 2004; Bartel, 
2004; Hagan and Croce, 2007; He and Hannon, 2004; Kloosterman and Plasterk, 2006)]. 
It is clear that miRNAs are absolutely essential for early animal development. Dicer 
knock-out mice die around embryonic day 7.5 as a consequence of stem cell depletion 
(Bernstein et al., 2003). A D. melanogaster mutant for Dicer-1 also displays problems with 
germ-line stem cell maintenance (Lee et al., 2004b). Zebrafish embryos lacking zygotic as 
well as maternally provided Dicer are able to differentiate into several cell types but 
display abnormalities during gastrulation, somitogenesis, brain and heart development 
(Giraldez et al., 2005). Later in animal development, miRNAs have been found to play a 
role during developmental timing. In C. elegans, lin-4 and let-7—the first miRNAs that 
were discovered—warrant proper transition of the larval stages by regulating 
heterochronic genes (Abrahante et al., 2003; Grosshans et al., 2005; Lee et al., 1993; Lin 
et al., 2003; Pasquinelli et al., 2000; Wightman et al., 1993). Also, signaling pathways that 
are important in animal development are subjected to miRNA-mediated regulation. In 
particular, target genes of the Notch pathway in D. melanogaster are regulated by miRNAs 
(Lai et al., 2005). 
Concerning cellular functions and metabolism, miRNAs have been shown to 
affect apoptosis and energy homeostasis both in flies and vertebrates (Brennecke et al., 
2003; Poy et al., 2004; Teleman et al., 2006). During organogenesis, muscle and heart 
development is regulated by miRNAs with high phylogenetic conservation (Aboobaker 
et al., 2005; Chen et al., 2006; Naguibneva et al., 2006; Sokol and Ambros, 2005; 
Tuddenham et al., 2006; Zhao et al., 2005). Probably the most interesting organ that 
shows extensive regulation by miRNAs is the brain. The functions of miRNAs range 
from differentiation of neuronal progenitor cells (Conaco et al., 2006) over neuronal 
outgrowth and morphogenesis (Vo et al., 2005) to synaptic plasticity (Schratt et al., 2006). 
Over the past few years, more and more evidence was put forth that aberrant 
expression of miRNAs also contributes to the oncogenic potential of tumorigenic cells, 
providing a link between miRNAs and cancer (Calin and Croce, 2006; Calin et al., 2004a; 
Calin et al., 2004b; Ciafre et al., 2005; Volinia et al., 2006; Yanaihara et al., 2006). 
Interestingly, most miRNAs show a lower level of expression in tumor tissue leading to a 
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loss of cellular differentiation (Lu et al., 2005; Thomson et al., 2006) underlining the role 
of miRNA in promoting cellular differentiation. 
3.4. Other small RNA silencing pathways 
3.4.1. piRNAs 
The cloning and sequencing of small RNA populations from D. melanogaster led 
to the identification of 24 to 29-nt-long RNAs next to the expected 22-nt miRNAs 
(Aravin et al., 2003). These longer RNA molecules were found to associate with 
Argonaute proteins from the Piwi subfamily (Aravin et al., 2006; Brennecke et al., 2007; 
Carmell et al., 2007; Girard et al., 2006; Grivna et al., 2006a; Grivna et al., 2006b; 
Gunawardane et al., 2007; Saito et al., 2006; Vagin et al., 2006; Watanabe et al., 2007). 
Hence, these RNA molecules were named piRNAs, short for Piwi-associated RNAs. 
Interestingly, piRNAs are not encoded as hairpins (Betel et al., 2007). Thus, their 
biogenesis is completely different from miRNAs. piRNAs are generated in an 
amplification loop, where—in D. melanogaster—sense piRNAs associated with Ago3 
cleave long antisense RNA thereby setting the 5!-end of the antisense piRNAs that 
associate with a different Argonaute protein, called Aubergine. The antisense piRNA in 
Aubergine cleaves long sense RNAs forming the 5!-end of sense piRNAs. This process is 
called the “ping-pong model” (Brennecke et al., 2007; Gunawardane et al., 2007). The 
formation of the 3!-end is still unknown. In D. melanogaster, piRNAs are enriched for 
sequences from transposons and repeats, whereas in the mouse and rat, only 17% of all 
piRNAs map to repetitive elements (Hartig et al., 2007). Nonetheless, genetic analysis of 
Piwi-mutants suggests a conserved function of piRNAs in transposon control (Aravin et 
al., 2007; Carmell et al., 2007; Kalmykova et al., 2005; Sarot et al., 2004). 
3.4.2. RNA silencing and epigenetics 
3.4.2.1. Transcriptional gene silencing 
In plants, small RNAs do not only function on the post-transcriptional level but 
they can also lead to transcriptional gene silencing (Matzke and Birchler, 2005). This 
phenomenon is induced by dsRNA via de-novo DNA methylation followed by 
heterochromain formation (Mette et al., 2000; Wassenegger et al., 1994). A similar 
pathway exists in the fission yeast S. pombe, where dsRNA leads to the formation of 
repressive heterochromatin that silences gene expression (Volpe et al., 2002). The 
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effector complex is termed RITS (RNA-Induced Initiation of Transcriptional gene 
Silencing) and contains a short siRNA and an Argonaute protein (Motamedi et al., 2004; 
Verdel et al., 2004). RITS binds to nascent transcripts, interacts with modified histones 
and recruits chromatin-remodeling factors (Buhler et al., 2006; Motamedi et al., 2004; 
Noma et al., 2004). There is evidence that small RNA can mediate transcriptional gene 
silencing in animals, too (Fukagawa et al., 2004; Kanellopoulou et al., 2005; Kawasaki and 
Taira, 2004), but the detailed mechanisms and functions still remain obscure. 
3.4.2.2. Targeted DNA elimination 
During the sexual process of conjugation of ciliated protozoa such as 
Tetrahymena, the genome becomes extensively reorganized. This programmed deletion of 
DNA is mediated by an RNAi-related pathway (Mochizuki and Gorovsky, 2004, 2005), 
where sequences become marked for subsequent excision (Chalker and Yao, 2001; 
Mochizuki et al., 2002; Taverna et al., 2002; Yao et al., 2003). 
3.4.2.3. RNA silencing and Polycomb proteins 
Finally, RNAi components were found to play a role in silencing via Polycomb 
group proteins. In D. melanogaster, Dicer-2, PIWI and Argonaute1 appear to be required 
for long-distance physical interactions between chromosomes, indicating an involvement 
in higher-order nuclear organization (Grimaud et al., 2006; Lei and Corces, 2006). 
3.5. Aim of this thesis 
During my doctoral studies, I was focusing on upstream events in RNA 
silencing. This thesis can be divided into two parts. First, I was analyzing the process of 
RISC assembly. Much is known about this process, yet what happens exactly to the 
siRNA, when it is finally loaded into the Argonaute protein, was still elusive. The aim 
here was to characterize crucial steps during this process and the potential impact on 
silencing efficiency. Secondly, I was interested if miRNA-processing can be regulated, a 
hitherto completely unknown field, since it was generally accepted that differential 
expression of miRNA genes is exclusively achieved via transcriptional control. I envision 
that insights into this phenomenon will certainly lead to a more complete understanding 
of miRNA expression and target regulation. 
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4. Results 
4.1. Cleavage of the siRNA passenger strand during 
RISC assembly in human cells 
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Supplemental Figures 
 
Figure S1. Affinity purified RISC is not able to cleave a short RNA substrate displaying a 4S-U 
modification adjacent to the cleavage site (4S-U10). 
(A) Graphic representation of 4S-U-modified short RNA substrates. 4S-U-modifications are depicted as 
bars. Affinity-purified RISC (purified as previously described (Martinez et al., 2002)) is depicted in black 
below the guide strand. RNA substrates were 5! phospho-radiolabeled. 
(B) Phosphorimaging analysis of a cleavage reaction resolved in a 15% denaturing gel electrophoresis. 
Arrows point to the 4S-U-modified RNA substrates and the labeled 5! cleavage product.  
 
 
Figure S2. Initial assembly of RISC is not disturbed by modifications on the passenger strand that 
impair target RNA cleavage and occurs on a double-stranded siRNA. 
(A) Graphic representation of duplex siRNAs containing chemically modified or unmodified passenger 
strands (2´-O-methyl groups are depicted as circles), and a 5! phospho-radiolabeled guide strand modified 
at position 10 with 4S-U (4S-U10; depicted as a bar) to allow the cross-linking of proteins in close 
proximity to the center of the siRNA. 
(B) Phosphorimaging of a cross-linking reaction using siRNAs depicted in (A) resolved on a 7.5% SDS-
polyacrylamide gel. 
(C) Graphic representation of siRNAs composed of a 5! phospho-radiolabeled passenger strand modified 
with 4S-U10 and an unmodified guide strand, or an unmodified passenger strand annealed to a 5! 
phospho-radiolabeled guide strand modified with 4S-U10. 
(D) Time course analysis on the gradual recruitment of Ago2 to the siRNA, as monitored by cross-linking 
to both the guide and the passenger strands, resolved on a 7.5% SDS-polyacrylamide gel.
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Figure S3. Non-cleavable passenger strands are not released from the siRNA. 
(A) Graphic representation of the experiment. HeLa cytoplasmic extract was incubated together with 5 nM 
unmodified siRNA. After 15 min, when RISC assembly has already occurred, different amounts of both non-cleavable 
or cleavable passenger strands were added. At 30 min, the complementary target-RNA (10 nM) was introduced and the 
cleavage reaction was continued for 2 h. (B) Phosphorimaging analysis of the cleavage reaction described in (A) 
resolved in a 6% denaturing gel electrophoresis showing the effect of the addition of a single-stranded, non-cleavable 
or cleavable passenger strands on target-RNA cleavage. Since addition of 5 nM single stranded, non-cleavable 
passenger strand caused no significant reduction in target-RNA cleavage, re-binding of a potentially released non-
cleavable passenger strand from the siRNA duplex (also 5 nM) could not account for the drastic inhibition of target-
RNA cleavage. Only when added in large excess (50 nM), enough non-cleavable passenger strand molecules managed 
to escape unspecific degradation in the extract and acted as ‘suicide targets’. An unmodified passenger strand did not 
impair cleavage, not even at 50 nM, most probably because it was immediately cleaved by functional RISC and then 
released. (C) Graphic representation of the experiment. HeLa cytoplasmic extract was incubated together with 
different concentrations of siRNAs containing either cleavable or non-cleavable passenger strands. The capturing RNA 
(complementary to the passenger strand) was added after 5 minutes of initiating the reaction, to prevent premature 
degradation. (D) Phosphorimaging analysis of the cleavage reaction described in (C) resolved in a 6% denaturing 
gel electrophoresis showing the effect of adding a capturing RNA, complementary to the passenger strand, to a target-
RNA cleavage reaction. The addition of the capturing strand to cleavage reactions programmed with siRNAs featuring 
a cleavable passenger strand did not affect target-RNA cleavage. The reduction in target-RNA cleavage observed when 
using 0.5 nM siRNA is due to sub-saturated levels of RISC. Importantly, addition of the capturing strand to siRNAs 
featuring a non-cleavable passenger strand never rescued target-RNA cleavage, not even when the capturing strand was 
in a 10-fold excess over the siRNA. Taken these data together, we conclude that a non-cleavable passenger strand is 
never released from the original duplex, probably because its cleavage does not take place, resulting in inhibition of 
target-RNA cleavage through impairment of RISC assembly.  
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Figure S4. The passenger strand is cleaved during RISC assembly. 
Picture of the whole gel depicted in Fig. 2D showing the concomitant 3!–5! exonucleolytic degradation of 
the passenger strand. This degradation leads to the steady accumulation of <21 nt species during the 
course of the reaction irrespective of the passenger being cleaved during RISC assembly. The region of the 
gel corresponding to sizes between 8 and 12 nt has been enhanced for an optimal visualization of the 
cleavage products.  
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4.2. Post-transcriptional regulation of microRNA 
expression 
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Supplemental Figures 
 
Figure S1. 
Multiple sequence alignments of the flanking regions of chromosomal loci encoding miR-138. Regions in 
red represent >90%, and regions in green 50–90% sequence homology. Note, that the pre-miR-138-2 
surrounding sequences are highly conserved, while this is not the case for miR-138-1. (Abbreviations: Mm 
= Mus musculus; Rn = Rattus norvegicus; Cf = Canis familiaris). 
 
 
 
Figure S2. 
Northern blot analysis of total RNA from adult mouse brain and liver. A probe containing a central, 
contiguous 6-nt mismatch spanning the boundary between the mature miRNA and the loop region 
(mismatch loop) does not recognize the 69-nt band that is observed when probing for the loop or pre-
miR-138-2 (match loop). A probe against the mature miR-138-2 that contains mismatched nucleotides 
(mismatch mature) also unable to detect the 69-nt band. The lower panel shows an enhanced picture. 
Philipp JF Leuschner Results 45 
 
 
Figure S3. 
(A) High magnification images of in situ hybridization experiments on cryo-sections of fetal mouse brain, 
showing the expression of mature miR-138 in neocortex.  
(B) As (A) with the exception that the section was probed for pre-miR-138-2. 
(C) High magnification images of in situ hybridization experiments on cryo-sections of adult mouse 
cerebellum, showing the expression of mature miR-138 in the granule cells (G) and in the Purkinje cell 
layer (P) of the cerebellum.  
(D) The levels of pre-miR-138-2 are lower in the above mentioned cell layers, indicating an efficient 
conversion of pre-miR-138-2 into the mature miR-138, and a consequent depletion of the precursor. 
 
 
 
 
 
Figure S4. Northern blot analysis of pre-miRNA processing in HeLa cells. 
(A) HeLa cells were transfected with the indicated amounts of a plasmid encoding the sequence of pre-
miR-124a. The conversion of pre-miR-124a into mature miR-124a was monitored by Northern blotting. 
(B) HeLa cells were transfected with the indicated amounts of a plasmid encoding the sequence of pre-
miR-138-2. In contrast to pre-miR-124a, HeLa cells failed to process pre-miR-138-2 into mature miR-138. 
Note that pre-miR-138-2 is more abundant than pre-miR-124a. 
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4.3. Analyzing the mechanism for differential, context-
dependent microRNA processing 
4.3.1. An inhibitory factor blocks processing of pre-miR-138-2 
Since the in vitro processing experiments clearly indicate the existence of a 
specific negative regulator for Dicer-mediated cleavage of pre-miR-138-2, the most 
intriguing and immediate questions were, what constitutes this inhibitory factor, and does 
it act in trans or in cis? We addressed this problem by splitting the in vitro cleavage assay 
with recombinant Dicer and cellular extracts into two parts: first, the 5! radiolabeled 
substrate was pre-incubated in protein extracts that are thought to either contain or lack 
the inhibitor. Second, following proteinase K digestion, phenol-chloroform extraction of 
the RNA, ethanol precipitation and refolding in RNA structure buffer, cleavage by 
recombinant Dicer was evaluated. If the inhibitory factor acted in trans, e.g. by modifying 
the precursor, a difference in processing efficiency should be visible even after removing 
it; if not, this would indicate that the inhibitory factor acted in cis, meaning that it needs 
to bind the precursor in order to block processing by Dicer. Since fluorescence in situ 
hybridization experiments showed that miR-138 is matured in fetal liver but is absent in 
adult liver, I chose to generate cellular extracts from these two tissues.  
 
 
 
Figure 4. In v i t ro  processing 
assay of pre-miR-138-2 by 
recombinant Dicer. 
5!-end radiolabeled pre-miR-138-2 
was pre-incubated in fetal (middle 
panel) or adult mouse liver extracts 
(right panel). Dicer-mediated 
cleavage was assessed after 
removing the protein fraction by 
proteinase K digest, 
phenol/chloroform extraction, 
ethanol precipitation and 
reannealing in assay-buffer. The left 
panel displays a control cleavage 
assay performed in the presence of 
high concentrations of bulk RNA 
(tRNA). 
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Figure 4 demonstrates that there are no visible differences in the processing of 
substrates that were differentially pre-treated prior to Dicer cleavage. This indicates that 
an enzymatic modification of pre-miR-138-2 during the pre-incubation is rather unlikely 
to be the cause of inhibition. First, processing of pre-miR-138-2 by recombinant Dicer is 
abolished very quickly after the addition of an inhibiting cellular extract. Second and 
more important, a longer pre-incubation in the extract did not affect the subsequent 
enzymatic processing of the substrate that was carried out after removing the protein 
present in the extract by proteinase K digestion. Furthermore, one can also rather 
disregard an RNA-molecule as the inhibiting factor that could anneal to parts of the pre-
miR-138-2 hairpin thereby altering the overall geometry and thus impeding processing. 
Such an RNA inhibitor should have been imported into the processing reaction during 
the phenol-chloroform extraction and should have annealed to pre-miR-138-2 during 
refolding in the assay buffer. The most plausible candidate for the inhibitor therefore is a 
protein that, by interacting specifically with pre-miR-138-2, abolishes cleavage by Dicer. 
In tissues that do mature pre-miR-138-2 this protein may not be expressed or may be 
modified—by alternative splicing or post-translationally—to render it unable to bind pre-
miR-138-2. 
4.3.2. How does the inhibitor recognize pre-miR-138-2? 
A recurring question concerning post-transcriptional regulation of pre-miR-138-
2 processing is, what attributes of the pre-miRNA are recognized by the regulating 
factor? The secondary structure of pre-miR-138-2 features two unpaired nucleotides at 
the 5!-end, two internal loops and a single nucleotide bulge close to the terminal loop 
(Figure 5A). Dicer cleavage occurs adjacent to the second internal loop yielding the ~23-
24 nt miR-138. To check whether these internal loops play a role in the recognition of 
pre-miR-138-2 by the inhibitor, I generated mutant pre-miR-138-2-hairpins, where the 
sequence of the miRNA* strands were altered in order to close the first, the second and 
also both loops. Figure 5A displays the structure of the different pre-miRNA hairpins. 
Hairpin precursors were 5!-end labeled with 32P-"-ATP and compared in in vitro 
processing assays using recombinant Dicer alone or in the presence of the inhibiting 
HeLa S100 cytoplasmic extract (Figure 5B). In contrast to loop 2, closing of loop 1 alone 
(pre-miR-138-2-L1) was enough to largely abolish the inhibition of Dicer cleavage on 
pre-miR-138-2, suggesting that the inhibitor recognizes loop 1. Another interesting 
observation is that closing of either loop has an impact on the size of Dicer’s cleavage 
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products. The genuine pre-miR-138-2 yields 23-nt and 24-nt miRNA species at a 1:1 
ratio. Closing loop 1 (pre-miR-138-2-L1) shifts the cleavage site and generates a single 
miR-138 species of 23 nt, whereas closing loop 2 (pre-miR-138-2-L2) favors the 24-nt 
species. If both loops are closed (pre-miR-138-2-L1L2), the most abundant species is the 
23-nt miR-138. 
 
Figure 5. Analysis of the secondary structure of pre-miR-138-2 and its involvement in differential 
processing 
(A) Secondary structure predictions of the four different pre-miR-138-2 hairpins used to assess the 
structure requirements of inhibitor binding. The upper hairpin displays the genuine sequence of pre-miR-
138-2. The mature miR-138 sequence is indicated in bold. The loops were closed by adjusting the sequence 
of the miR-138* arm. (B) In vitro Dicer-processing reaction of the pre-miR-138-2 structural variants 
displayed in (A). The pre-miR-138-2 hairpins were 5! end labeled using "-32P-ATP and processed using (a) 
recombinant Dicer enzyme alone and (b) recombinant Dicer enzyme plus HeLa cytoplasmic extract (S100). 
The processing of the hairpin by Dicer alone indicates correct folding and recognition as a genuine pre-
miRNA. The addition of HeLa cytoplasmic extract to the processing reaction indicates, whether the 
hairpin is still recognized by the inhibitor. Closing of the loop 1 greatly abolishes inhibition of processing. 
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4.3.3. Purification of the inhibitory factor 
4.3.3.1. Classical chromatography 
Since we performed the in vitro processing assays using HeLa cytoplasmic 
extracts and since such extracts are readily available in large quantities, an obvious 
endeavor was to attempt the purification of the inhibitor employing classical 
chromatography. After a period of scouting various resins for the ability to retain and 
elute the inhibitory activity upon changes in the salt concentration, I was able to 
concatenate seven purification steps leading to a specific enrichment (Figure 6). The aim 
was to reduce the number of proteins co-eluting with the inhibitory activity to a 
reasonable figure, where the candidate proteins could then be evaluated. The validation 
of candidate proteins consisted of (a) an RNAi-mediated knock-down of the factor in 
HeLa cells and subsequent testing of the cellular extract in an in vitro processing reaction 
for a lack of inhibition and (b) recombinant expression of the factor in bacteria and 
testing the protein in in vitro processing assay for inhibition of pre-miR-138-2 processing. 
 
 
Figure 6. Chromatographic purification 
strategy for the inhibitor of pre-miR-138-2 
processing. 
HeLa S100 cytoplasmic extract was applied to the 
designated resins using buffers indicated below 
the scales (“BA” = buffer A, etc.). The numbers 
given below the scales indicate the molarity of 
KCl, or KPi in the case of BD, in [mM] in the 
eluted fractions, where the inhibiting activity was 
detected. These fractions were pooled and 
dialyzed to the buffer conditions used in the 
following column. 
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The ability to inhibit Dicer-mediated processing of a 5!-radiolabeled pre-miR-
138-2 substrate was used to assay the fractions for the presence or absence of the 
inhibitor. We confirmed the specificity of the inhibitor for pre-miR-138-2 by also 
assaying the fractions for cleavage of pre-miR-19a, a miRNA abundant in HeLa cells. 
Figure 7 displays autoradiographies of denaturing polyacrylamide gels loaded with such 
processing reactions after the sixth purification step (Blue Sepharose, see Figure 6). pre-
miR-19a was processed in all fractions, including the input, with roughly the same 
efficiency indicating the specificity of the inhibitor towards binding pre-miR-138-2, 
where processing was inhibited strongly in a restricted set of consecutive fractions. 
 
 
 
Figure 7. In v i t ro Dicer-processing reaction of pre-miR-19a (left) and pre-miR-138-2 (right) using 
the fractions collected from the 6th purification step (Blue Sepharose) 
Each fraction collected from the elution of the Blue Sepharose column was assayed for the presence of the 
inhibitory factor by in vitro processing using recombinant Dicer enzyme. While processing of pre-miR-138-
2 was inhibited in several fractions, this phenomenon was not observed for the processing of pre-mir-19a. 
 
After the final purification step, the fractions were precipitated using TCA and 
loaded onto an SDS-polyacrylamide gel. The protein content was visualized by silver 
staining followed by mass-spectrometry to identify the proteins. The in vitro processing 
assay and the silver staining of the SDS-PAGE are shown in Figure 8. The last 
purification step in the purification chain was a 5–20% glycerol gradient (Figure 6), 
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where protein complexes sediment according to their molecular weight. The 
sedimentation coefficient of the inhibitory activity was determined to be 4.5 S, 
corresponding to a size of ~50–70 Da (The standard bovine serum albumine [BSA] with 
a molecular weight of 66 kDa sediments at 4.6 S). However, we could not 
macroscopically identify protein bands running at the determined size range on the silver 
gel, which also co-fractionate with the inhibitory activity. We therefore compared liquid 
samples taken (a) from a fraction with peak activity (fraction 5, “LiqPlus”) and (b) from a 
fraction with no activity (fraction 12, “LiqMinus”). The mass spectra can be seen in 
appendix A (pages 54–58). 
 
 
Figure 8. In v i t ro Dicer-processing reaction of pre-miR-138-2 (left) and silver staining of a SDS-
PAGE (right) of fractions 1–10 from the last purification step (glycerol gradient) 
The fractions 1 to 10 collected from the 5–20% glycerol gradient were assayed using the in vitro processing 
assay. Strong inhibition was observed in fractions 4–7. These fractions are indicated in the silver staining by 
dotted lines. Candidate bands that only show up between these boundaries were cut out and sent for 
identification by mass-spectrometry. 
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4.3.3.2. Affinity purification using the StreptoTag 
Despite a considerable enrichment of the inhibitor during the seven purification 
steps, silver gel analysis and mass-spectrometry still yielded a large number of candidate 
proteins co-eluting with the inhibitory activity. This complicated the selection and testing 
of candidate genes. Therefore, I chose to apply a different purification strategy relying 
solely on affinity chromatography, called StreptoTag (Windbichler and Schroeder, 2006). 
Here, the streptomycin RNA aptamer is fused to an RNA sequence, whose binding 
partners are to be determined. This hybrid RNA is subsequently immobilized on a 
streptomycin affinity matrix. The protein mixture is applied to the resin, washed 
extensively and finally eluted by the addition of excess streptomycin allowing the 
recovery of RNA–protein complexes. To reduce the complexity of the extract, I pre-
purified the inhibitory activity. During the scouting period for the classical 
chromatography, I noticed that both Heparin-coupled Sepharose and Blue-Sepharose 
displayed a very strong affinity to bind and retain the inhibitor. It elutes at >500 mM KCl 
from Heparin Sepharose and at >1.6 M KCl from Blue-Sepharose (Figure 6). This 
allowed me to concatenate these two resins without the need for dialysis in between to 
pre-purify the inhibitor from HeLa cytoplasmic S100 extract for StreptoTag 
chromatography.  
The RNA fusion-oligonucleotide featured the pre-miR-138-2 structure at the 5!-
end, the streptomycin aptamer (StreptoTag) at the 3!-end and a 6 nt spacer in between 
(Figure 9). In vitro processing assays of this RNA oligonucleotide showed a weak affinity 
of Dicer to cleave the embedded pre-miR-138-2 hairpin. However, the addition of HeLa 
S100 abolished this cleavage indicating that the inhibitor effectively binds this fusion 
RNA construct (data not shown). The eluate of the StreptoTag purification was analyzed 
by mass-spectrometry. The spectra can be seen in appendix B (page 51). 
 
 
Figure 9. Fusion RNA oligonucleotide used in StreptoTag affinity purification 
(A) Design of the RNA fusion oligonucleotide consisting of the pre-miR-138-2 at the 5! end and the 
streptomycin aptamer at the 3! end. The mature miR-138 is indicated in red. (B) Secondary structure 
prediction of the RNA fusion oligonucleotide using RNAfold. 
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4.3.3.3. Size exclusion chromatography 
Gel filtration was not used during the purification chain described in 4.3.3.1 
because of excessive dilution of the inhibitory activity, which could no longer be 
observed in the in vitro processing assay. For the StreptoTag method, the pre-purification 
of the inhibitory activity using Heparin Sepharose and Blue Sepharose generated a 
sample, which was highly enriched for the inhibitor. We therefore chose this approach to 
pre-purify the activity for subsequent size exclusion chromatography and succeeded in 
determining the size of the inhibitor at around 15 kDa. Interestingly, this figure is 
different from the molecular weight determined in the glycerol gradient. While the 
inhibitory activity sedimented at 4.5 S (~50–70 kDa) in the glycerol gradient, the size 
exclusion chromatography suggests a smaller size, ~15–20 kDa (Figure 10). This 
probably explains, why we never observed a protein band in the silver gels co-eluting 
with the inhibitory activity in the processing gels (Figure 8), since we were looking at 
bands with a molecular weight greater than ~25 kDa. 
 
 
Figure 10. Fractions from the size exclusion chromatography assayed for the presence of the 
inhibitory activity by in v i t ro Dicer-processing of pre-miR-138-2 
The fractions collected from the size exclusion chromatography were assayed using the in vitro processing 
assay. Inhibition of processing was observed in fractions corresponding to a size of ~15–20 kDa. 
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5. Discussion 
5.1. Passenger strand cleavage for efficient RNAi 
The studies on passenger strand cleavage in human cells and D. melanogaster 
showed that siRNAs are loaded into RISC while still being in the duplex configuration 
(Leuschner et al., 2006; Matranga et al., 2005; Miyoshi et al., 2005; Rand et al., 2005). 
Earlier models implied an elusive RNA helicase to remove the passenger strand prior to 
RISC assembly (Pham et al., 2004). Still, the hypothesis of an RNA helicase removing the 
cleavage products during RISC loading as well as during RISC recycling under multiple 
turnover conditions is valid. Since recombinant Ago2 can only be programmed by single-
stranded siRNAs (Rivas et al., 2005), this immediately suggests that the role of a putative 
RISC loading complex (RLC) is to enable the loading of a duplex siRNA into Ago2 
(Pham et al., 2004). In the human context, the phenomenon of passenger strand cleavage 
remains obscure. In contrast to D. melanogaster, no RLC or holo-RISC has been described 
most probably owing to the fact that the RNAi pathway does not exist. However, 
challenging the cells with “Dicer-like” pre-processed siRNAs provokes strong silencing. 
In this case, passenger strand cleavage takes place and is an important prerequisite. Since 
passenger strand cleavage enforces siRNA asymmetry by destroying one strand thus 
removing it from the scene, this could be valuable for the future design of synthetic 
siRNAs. Rendering the guide strand “uncleavable” but still functional by a 
phosphorothioate between the nt 9 and 10 should prevent RISC from stochastic loading 
onto the passenger strand thus removing off-target effects without altering the efficiency 
and specificity of the guide strand. 
Concerning the bypass mechanism, where an intact passenger strand has to be 
removed, two important questions need to be addressed: (a) how does Ago2-RISC 
remove the miRNA* strand where central mismatches impede passenger strand cleavage; 
(b) how do human Ago1, Ago3 and Ago4—that associate with siRNAs and miRNAs but 
lack slicer activity (Liu et al., 2004; Meister et al., 2004)—remove the passenger strand? 
Matranga and colleagues addressed these problems beautifully in D. melanogaster and 
HeLa cells (Matranga et al., 2005). In accordance with our results, the bypass pathway 
acts slower in unwinding the duplex, when compared to the cleavage-assisted pathway. 
An important consequence of passenger strand cleavage within an siRNA is the dramatic 
change in the thermodynamic profile of the duplex, making it easier to unwind. It 
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appears that especially the bases of the seed have to be unpaired to dismantle RISC from 
the target. Matranga and colleagues compared the genuine miR-1/miR-1* duplex 
featuring a 2-nt bulge at the seed, a “miR-1-siRNA” with perfect baseparing over the 
whole duplex and a “miR-1-GU-siRNA”, where a bulge was introduced at position 2 of 
miR-1 (Figure 11). In addition, the passenger strands either featured phosphates or 
phosphorothioates between bases 9 and 10 thus rendering it cleavable or uncleavable, 
respectively. In stark contrast to both miR-1-siRNA types, the miR-1/miR-1* miRNA 
duplex with an uncleavable passenger strand did not show significant drop in silencing 
efficiency. The biggest decrease in target RNA cleavage was observed for the miR-1-
siRNA. For the miR-1-GU-siRNA, this effect was lower but still significant. 
 
 
 
The main conclusion from these results is that a bulge in the seed region 
abrogates the necessity for passenger strand cleavage. In this case the bypass pathway is 
able to unwind the duplex fast and easily. A GU-pair in the seed also assists unwinding, 
albeit at a much reduced speed if the passenger strand cannot be cleaved. These findings 
are very important in the context of the slicer-dead Argonaute proteins Ago1, Ago3 and 
Ago4. Here, even if the passenger strand could be cleaved, cleavage would not happen 
and the passenger strand has to be removed intact. Comparing known miRNA/miRNA* 
duplexes (Griffiths-Jones, 2004) it becomes evident that many feature at least one 
unpaired base within the seed, which will greatly assist unwinding during RISC loading. 
This is in line with current publications underlining the importance of target RNA 
binding via the bases of the seed. It appears that the seed, which was originally described 
for miRNAs, also plays an important role for siRNAs in finding and binding a target 
(Ameres et al., 2007): the bases of the 5! create a thermodynamic threshold that has to be 
overcome to allow a stable association of RISC to the target RNA—an mRNA or even 
the passenger strand. 
Figure 11. Analyzing the 
bypass pathway 
Matranga et al. compared 
passenger strand removal on 
the genuine miR-1 duplex to a 
miR-1-siRNA with perfect 
complementarity and to a 
miR-1-GU-siRNA with a GU-
basepair at position 2 of miR-
1. The scissile phosphodiester-
bond either contained a 
phosphate (PO) or a 
phosphorothioate (PS). 
taken from (Matranga et al., 
2005) 
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5.2. Differential, context-dependent processing of pre-miR-
138-2 confers tissue specificity 
5.2.1. Modes of post-transcriptional regulation of microRNA 
expression 
Shortly after the publication of our results, more evidence on post-
transcriptional regulation of miRNA expression surfaced. While the phenomenon we 
observed was restricted to a single pre-miRNA hairpin, Thomson and colleagues 
reported extensive post-transcriptional regulation of miRNA expression at the level of 
Drosha processing (Thomson et al., 2006). They found that both in early mouse 
development and primary tumors, the level of the nuclear RNase III Drosha, which 
initiates the miRNA processing cascade, is down-regulated while miRNA genes are being 
transcribed. This leads to an accumulation of primary transcripts with no mature 
miRNAs present. These findings are in line with the current view that the expression of 
the large majority of miRNAs is induced during mid-to-late embryonic development, 
culminating in adult and terminally differentiated tissues (Kloosterman and Plasterk, 
2006). Thus, miRNAs are hypothesized to mainly function by “freezing” the terminally 
differentiated status of cells (Bartel and Chen, 2004). In primary tumors, many miRNAs 
can be found to be down-regulated, which could indicate a loss of cellular differentiation 
(Lu et al., 2005; Takamizawa et al., 2004). While this down-regulation could be attributed 
to transcriptional modulation on the miRNAs promoter level, it is tempting to speculate 
that a down-regulation of Drosha could globally lead to the same effect. Further 
evidence for extensive post-transcriptional regulation of miRNA expression was put 
forward by van Rooij and colleagues, who analyzed miRNA expression signatures 
associated with cardiac hypertrophy (van Rooij et al., 2006). In several cases, they 
observed differential accumulation of mature miRNAs versus their pre-miRNA hairpins. 
However, they did not analyze these observations further to assess, whether these 
variable ratios could be explained by regulation of Drosha or Dicer or whether they are 
due to other phenomena. 
Kawahara and colleagues reported RNA A!I editing of a pri-miRNA to be 
responsible for differential processing of the resulting pre-miRNA (Kawahara et al., 
2007). Such editing by Adenosine Deaminases Acting on RNA (ADARs) has already 
been described earlier (Yang et al., 2006), but the fate of edited pri-miRNAs was largely 
 Discussion Philipp JF Leuschner 62 
unknown. Kawahara and colleagues showed that the conversion of two specific 
adenosine residues to inosine on the pri-miR-151 interfered with the interaction between 
the pre-miR-151 and the Dicer-TRBP complex. However, this A!I editing of pri-miR-
151 in neuronal tissues is not absolute. Approximately 60–70% of the pre-miR-151 
transcripts remain unedited in neuronal cells and are processed faithfully to the mature 
miR-151. This is a major difference to the phenomenon we described, where we observe 
a complete block in the processing of pre-miR-138-2 to mature miR-138. It appears that 
editing of pri-miR-151 is used to adjust the levels of miR-151 in neuronal tissues. 
Guil and Caceres provided the latest contribution to post-transcriptional 
regulation. In contrast to all previous examples, where miRNA expression is negatively 
regulated, Guil and Caceres described an auxiliary factor that acts positively on miRNA 
processing (Guil and Caceres, 2007). hnRNP A1 was found to bind specifically to the 
pri-miR-18 hairpin within the primary transcript of the miR-17–92 cluster, and assist in its 
cleavage by Drosha. If cells are depleted of hnRNP A1, the amounts of pre-miR-18 and 
mature miR-18 are significantly lower. hnRNP A1 is known to be expressed in a tissue 
specific manner (Hanamura et al., 1998), indicating a potential involvement in regulating 
tissue specific miRNA expression. Furthermore, the dependency of an auxiliary factor to 
efficiently process a miRNA hairpin from a polycistronic miRNA-cluster elegantly 
uncouples its expression from the other co-transcribed miRNAs and allows function 
independent from the polycistron. 
These studies have been published within one year and, in my opinion, 
constitute just the starting point in the field of post-transcriptional regulation of miRNA 
expression. The early view, where the miRNA biogenesis cascade was thought to be a 
default pathway, that is executed as soon as a miRNA gene is transcribed, has been 
overhauled thoroughly. Still, it remains undisputed that regulation on the promoter level 
has the biggest contribution to tissue- and developmental stage-specific expression of 
miRNAs. However, after the stage is set, cells employ additional tricks during miRNA 
maturation to finetune and modulate the expression of specific miRNAs. This allows 
complex regulation at various positions.  
5.2.2. Purpose of post-transcriptional regulation of microRNA 
expression 
The question remains, what could be the biological relevance of post-
transcriptional regulation? In most cases, the purpose appears to be evident. Regulation 
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by pri-miRNA editing seems to fine-tune the level of the mature, functional miRNA. 
Neuronal cells obviously require a lower amount of miR-151 than other tissues. Another 
reason could be the uncoupling of one miRNA from other co-transcribed RNAs. Such 
RNAs can be different miRNAs residing in the same polycistron, but also an mRNA, 
where the particular miRNA is residing in an intron. As a consequence, the miRNA will 
be expressed, whenever the host-gene is transcribed, although the requirement for the 
host gene and the miRNA could be different. Regulation similar to hnRNP A1 and 
miR-18 could in this case ensure that the miRNA is only matured when needed. We 
hypothesized that this could be the explanation for the differential expression of miR-
138. We envisioned that the locus miR-138-2 could be encoded in an intron of a 
constitutively expressed gene. By post-transcriptional regulation, expression of the 
mature functional miR-138 is restricted to neuronal cells. However, analysis of the 
genomic context showed that miR-138-2 resides in an independent transcription unit. 
Thus, the purpose of post-transcriptional regulation of pre-miR-138-2 still remains 
obscure. 
5.2.3. Insights from the secondary structure of pre-miR-138-2  
Comparing the secondary structure of pre-miR-138-2 to other pre-miRNAs 
does not reveal any striking differences. Nevertheless, we envision that the inhibitor 
recognizes pre-miR-138-2 due to its sequence and the resulting secondary structure. 
Structural variants clearly showed that the internal loop 1, which is next to the open end 
of the hairpin precursor, plays a crucial role, since the closing of this loop abrogated 
inhibition of processing in HeLa cytoplasmic extract. However, it appears that this loop 
alone is not the only determinant, since removing the loop 2 next to the closed end of 
the hairpin also relieved inhibition, albeit only slightly. Obviously, the inhibitor 
recognizes the overall structure of pre-miR-138-2 and not isolated elements. Another 
interesting observation is the 17-nt cleavage product that accumulates whenever 
processing is inhibited (Figure 5 bottom of the gel). Counting from the 5!-end, 
nucleotide 17 is the cytidine base within the loop 1. While this could be easily dismissed 
as an artifactual activity of an unspecific nuclease in the in vitro cleavage assay, one should 
consider the fact that miR-138 was originally annotated as a 17-nt miRNA with a very 
low abundance (Tom Tuschl, personal communication). Could it be that loop 1 is not 
only important for the recognition by the inhibitor but also plays a role in the turnover of 
non-processed pre-miR-138? Since the miR-138-2 gene appears to be transcriptionally 
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active in a constitutive fashion and since faithful processing of pre-miR-138-2 by Dicer is 
inhibited, cells actually need an exit pathway to get rid of the otherwise accumulating pre-
miR-138-2. We never detected a 17-nt band in our Northern blots, probably due to the 
very short half-life of such an RNA oligonucleotide in the cell. We hypothesize that the 
inhibitor could fulfil a bipartite function: (a) to inhibit Dicer from processing pre-miR-
138-2 and (b) to mediate the degradation of unprocessed pre-miR-138-2. Still, this 
hypothesis needs experimental validation. A crucial question is, why the 17-nt band is 
absent, when the loop-1-mutant pre-miR-138 is processed in the presence of HeLa 
cytoplasmic extract? What is the requirement for cleavage to occur after nucleotide 17: 
the binding of the inhibitor or the single stranded configuration of the nucleotides 16–18 
in the loop? Both conditions are abrogated in the loop-1-mutant pre-miR-138-2. 
Analyzing the 17-nt cleavage product could shed some light. Does it display a 3!-hydroxy 
or a 3!-phosphate terminus? 
An unrelated observation from the processing studies of the structural mutants 
was the fidelity of Dicer cleavage. Northern blot analysis with a reasonable resolution at 
the size of ~21 nt shows that miRNAs do not exist as a single species but in various 
lengths within a margin of ±2 nt. As consistently shown in both Northern blots and 
processing gels, miR-138 exists as 23-nt and 24-nt miRNA species at ratio of around 1:1. 
If loop 1 is closed, the cleavage is shifted towards 23 nt, if loop 2 is closed the cleavage is 
shifted towards 24 nt. Our interpretation of this phenomenon is that an internal loop 
acts like a spring, conferring flexibility to the precursor hairpin. Depending on the state 
of this molecular spring—compressed or relaxed—Dicer cleaves after nucleotide 23 or 
24, respectively. Closing the loops removes the spring function and makes the structure 
rigid, leading to Dicer cutting the precursor at a single site. For miRNAs encoded in the 
5!-arm of the precursor hairpin, adding or removing a base at the 3!-end does not matter 
in terms of miRNA function. For miRNAs in the 3!-arm, however, Dicer sets the actual 
5!-end that is important for the location of the seed. Adding or removing one base here 
would shift the sequence of the seed and will eventually lead to different requirements to 
bind a target RNA. We envision the existence of sub-classes of target RNAs that are 
either bound by one or the other miRNA species. If the fidelity of Dicer cleavage on a 
given pre-miRNA could be modulated by the binding of additional interacting factors, 
such sub-classes of miRNA-target RNAs could be individually regulated, a hypothetical 
novel way of post-transcriptional regulation of miRNA function. 
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5.2.4. Purification attempts 
We have employed several techniques to purify the inhibitory activity from 
HeLa cytoplasmic extracts in order to allow identification of the protein factors involved. 
So far, no candidate could be positively validated from either purification strategy. For 
the future, we will attempt to combine the different strategies. First, I will perform 
glycerol gradient and gel filtration chromatography from the same pre-purified sample to 
determine the molecular size more accurately using the method of Siegel and Monty 
(Siegel and Monty, 1966). For the StreptoTag technique, I plan to add the gel filtration 
step to the pre-purification of the inhibitory activity after Heparin and Blue Sepharose. 
While the classical chromatographic purification chain leads to a specific enrichment, still 
a large number of proteins co elute with the inhibitory activity. Here, gel filtration could 
also potentially help to remove background. 
Finally, I also want to add western blotting to the validation of candidate 
proteins identified from liquid samples. If anti-sera are available, I plan to probe the 
fractions showing inhibitory activity plus the neighboring ones, in order to see co-
purification of the activity and the presence of the protein band on the western blot. 
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6.1. Chromatography 
6.1.1. Purification of the inhibitory activity from HeLa extracts  
The Lührmann lab, MPI Göttingen, generously provided cytoplasmic extracts 
prepared from HeLa cells according to the Dignam protocol (Dignam et al., 1983). The 
cytoplasmic fraction was supplemented to final concentrations of 100 mM KCl, 2 mM 
MgCl2 and 10% glycerol, frozen it in liquid nitrogen and stored it at –80ºC. S100 extracts 
were prepared by ultracentrifugation for 1 h at 29,000 rpm at 4ºC using a Sorvall T-1250 
rotor. The protein concentration of HeLa S100 extracts usually varied between 3-5 
mg/ml. The purification of the inhibitory activity is schematically shown in Figure 6. All 
procedures were carried out at 4ºC. Column fractions were assayed for inhibition of pre-
miR-138-2 processing by recombinant Dicer enzyme as described above. A total of 2,400 
ml HeLa S100 extract (~4 mg/ml) were divided into 6# 400 ml fractions that were 
individually loaded onto a Heparin Sepharose 6 FF column (XK26, 100 ml bed volume, 
GE Healthcare) equilibrated in buffer BA100 (100 mM KCl, 30 mM Hepes pH 7.4, 5 
mM MgCl2, 10% glycerol, 0.5 mM DTT, 0.1 mM AEBSF). Elution occurred over 800 ml 
of a linear gradient in buffer BA1000 containing 1 M KCl. The 500 mM–660 mM 
fraction (6# ~120 ml) was supplemented with 35% ammonium sulfate (23.9 g), left for 
15 min on ice, and centrifuged for 20 min at 16,000 rpm at 4ºC using a Sorvall SS34 
rotor. The supernatant was collected and supplemented with 24.8 g ammonium sulfate 
(65%), again left for 15 min on ice and centrifuged for 20 min at 16,000 rpm at 4ºC. 
Three pellets (2#) were combined and dissolved in 100 ml buffer BB30 (30 mM KCl, 30 
mM Hepes pH 6.0, 5 mM MgCl2, 10% glycerol, 0.5 mM DTT, 0.1 mM AEBSF) and 
loaded onto a HiPrep 16/10 SP FF column (20 ml bed volume, GE Healthcare) 
equilibrated with buffer BB30. The column was developed with a gradient over 10# 
column volumes (CV) to buffer BB1000 containing 1 M KCl. The active pool (320 mM–
490 mM) was dialyzed overnight against buffer BC100 (100 mM KCl, 30 mM Tris-HCl 
pH 8.0, 5 mM MgCl2, 10% glycerol, 0.5 mM DTT, 0.1 mM AEBSF) and applied to a 
HiTrap Q XL sepharose column (5 ml bed volume, GE Healthcare) equilibrated in 
buffer BB100. Protein was eluted with a gradient over 10# CV to buffer BC1000 (1 M 
KCl). The active pool (110 mM–-280 mM KCl) was dialyzed overnight against buffer 
BD10 (10 mM KPi pH 7.4, 10% glycerol, 0.5 mM DTT, 0.1 mM AEBSF) and applied to 
a Hydroxyapatite CHT-II column (1 ml bed volume, Biorad) equilibrated with buffer 
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BD10. The column was developed with a gradient over 10# CV to buffer BD500 
(containing 500 mM KPi). Fractions (250 mM–400 mM KPi) from the two inividual 
column runs were pooled, dialyzed overnight against buffer BA100 and loaded onto a 
single HiTrap Blue HP column (1 ml bed volume, GE Healthcare) equilibrated with 
buffer BA100. Protein was eluted with a gradient over 10# CV to buffer BA2000. The 
active pool (1600 mM–1800 mM KCl) was dialyzed overnight against buffer BA100 
containing only 3% glycerol and layered on top of a 12 ml linear 5% to 20% (w/w) 
glycerol gradient adjusted to 100 mM KCl, 30 mM Hepes pH 7.4, 5 mM MgCl2, 0.5 mM 
DTT. Centrifugation was performed for 20 h at 40,000 rpm at 4ºC using a Sorvall 
TH641 rotor. Standard proteins (bovine serum albumine [BSA], 4.6 S; aldolase 7.3 S; 
catalase, 11.3 S) were run in a parallel gradient. Twenty fractions of 0.6 ml were collected 
sequentially from the top. 0.5 ml of each fraction was precipitated overnight with 0.5 ml 
trichloroacetic acid (TCA). The precipitates were dissolved in SDS-PAGE loading buffer, 
and samples were analyzed by 10% SDS-PAGE followed by silver staining. Protein 
bands present in the active fractions were excised and analyzed by mass spectrometry, 
together with a sample from the liquid fraction. The protein samples were reduced with 
DTT, alkylated by iodine acetamide and trypsinized. Peptides were separated by nano-
HPLC chromatography and analyzed on a LTQ ion trap mass spectrometer. Mass data 
of all peptides were analyzed using the MASCOT software (Matrix Science).  
6.1.2. Determination of the molecular weight of the inhibitory 
activity  
To determine the molecular weight of the inhibitor, we performed size 
exclusion chromatography on a Superdex 200 column (Highload 16/60 column, GE 
Healthcare) using buffer BA100 as running buffer. The inhibitory activity was pre-
purified on a HiPrep Heparin FF column (5 ml CV) followed by a HiTrap Blue HP 
column (1 ml CV) without dialysis in between or thereafter. For column calibration, 
standard proteins were used (blue dextran, exclusion; catalase, rs = 5.2 nm, 250 kDa; 
aldolase, rs = 4.8 nm, 158 kDa; bovine serum albumin, rs = 3.6 nm, 66 kDa; RNase A, rs 
= 1.6 nm, 13 kDa). The native molecular weight of the inhibitory protein was determined 
to be approximately 20 kDa. 
 Materials and Methods Philipp JF Leuschner 74 
6.1.3. StreptoTag purification of the inhibitor 
The StreptoTag purification was performed as described in (Windbichler and 
Schroeder, 2006), using 200 pmol hybrid RNA immobilized on the column. The 
inhibitory activity was pre-purified using a HiTrap Blue HP column (see above). 
6.2. Mammalian cell culture  
HeLa cells were cultured at 37ºC, 95% humidity and 5% CO2 using Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum, 3 mM 
glutamine, 100 U/ml penicillin and 100 !g/ml streptomycin sulfate (all reagents were 
from Gibco) as a growth medium.  
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8. Abbreviations 
 
ADAR Adenosine deaminases acting on RNA 
b base(s) 
bp basepair(s) 
BSA bovine serum albumine 
CV column volume 
DNA deoxyribonucleic acid 
dsRBD double stranded RNA binding domain 
dsRNA double-stranded RNA 
min minute(s) 
miRISC miRNA-associated RISC 
miRNA microRNA 
mRNA messenger RNA 
Mw molecular weight 
ncRNA non-coding RNA 
nt nucleotide(s) 
p-bodies processing bodies 
PCR polymerase chain reaction 
pRNAs PIWI-associated RNAs 
RISC RNA induced silencing complex 
RITS RNA-Induced Initiation of Transcriptional gene Silencing 
RLC RISC loading complex 
RNA ribonucleic acid 
RNAi RNA interference 
rpm revolutions per minute 
rs Stoke’s radius 
siRNA short interfering RNA 
siRISC siRNA-associated RISC 
ssRNA single stranded RNA 
TCA trichloroacetic acid 
UTR untranslated region 
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